問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

陳志華CHEN, CHIH-HWA
  • Principal Investigator
  • Clinical Trial Experience (year) 7 years 10 個月

篩選

List

4Cases

2023-06-01 - 2026-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Not yet recruiting1Sites

Recruiting3Sites

2022-09-01 - 2024-12-31

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Not yet recruiting1Sites

Recruiting10Sites

2021-11-15 - 2023-12-30

Phase III

xxxxxx
  • Condition/Disease

    xxxxxx

  • Test Drug

    Ibuprofen Modified-Release Tablets 800 mg

Participate Sites
9Sites

Recruiting9Sites

2021-10-16 - 2022-10-15

Phase III

A Randomized, Double-blind, Placebo-controlled Phase III Trial to Evaluate the Efficacy, Safety, and Tolerability of Uni-TongXin Topical Herbal Patch in Patients with Acute Back Pain
  • Condition/Disease

    Low back Pain

  • Test Drug

    Uni-TongXin Topical Herbal Patch

Participate Sites
4Sites

Recruiting4Sites